The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Biological Drugs-Global Market Insights and Sales Trends 2024
Synopsis
The international biological drugs market is envisaged to grow at a handsome rate in the next few years. However, it could face challenges in the form of various product parameters, strict regulatory pathways and manufacturing processes, and longer product approvals, although biological drugs have historically shown better approval rates than conventional ones. Additionally, small players could find it difficult to enter the market because of the requirement of high capital expenditure.
The global Biological Drugs market size is expected to reach US$ 508960 million by 2029, growing at a CAGR of 8.2% from 2023 to 2029. The market is mainly driven by the significant applications of Biological Drugs in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers and Others,, are propelling Biological Drugs market. Therapeutic Protein, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Monoclonal Antibody segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biological Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biological Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biological Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biological Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biological Drugs covered in this report include Bristol-Myers Squibb, Eli Lilly, Takeda, Pfizer, Amgen, F. Hoffmann-La Roche, Johnson & Johnson, Merck and Abbott Laboratories, etc.
The global Biological Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol-Myers Squibb
Eli Lilly
Takeda
Pfizer
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Abbott Laboratories
Baxter
Novartis
Biogen
GlaxoSmithKline
Global Biological Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biological Drugs market, Segment by Type:
Therapeutic Protein
Monoclonal Antibody
Vaccine
Others
Global Biological Drugs market, by Application
Hospitals
Ambulatory Surgical Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Biological Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Biological Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The international biological drugs market is envisaged to grow at a handsome rate in the next few years. However, it could face challenges in the form of various product parameters, strict regulatory pathways and manufacturing processes, and longer product approvals, although biological drugs have historically shown better approval rates than conventional ones. Additionally, small players could find it difficult to enter the market because of the requirement of high capital expenditure.
The global Biological Drugs market size is expected to reach US$ 508960 million by 2029, growing at a CAGR of 8.2% from 2023 to 2029. The market is mainly driven by the significant applications of Biological Drugs in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers and Others,, are propelling Biological Drugs market. Therapeutic Protein, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Monoclonal Antibody segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biological Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biological Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biological Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biological Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biological Drugs covered in this report include Bristol-Myers Squibb, Eli Lilly, Takeda, Pfizer, Amgen, F. Hoffmann-La Roche, Johnson & Johnson, Merck and Abbott Laboratories, etc.
The global Biological Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol-Myers Squibb
Eli Lilly
Takeda
Pfizer
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Abbott Laboratories
Baxter
Novartis
Biogen
GlaxoSmithKline
Global Biological Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biological Drugs market, Segment by Type:
Therapeutic Protein
Monoclonal Antibody
Vaccine
Others
Global Biological Drugs market, by Application
Hospitals
Ambulatory Surgical Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Biological Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Biological Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Biological Drugs Market Overview
1.1 Biological Drugs Product Overview
1.2 Biological Drugs Market Segment by Type
1.2.1 Therapeutic Protein
1.2.2 Monoclonal Antibody
1.2.3 Vaccine
1.2.4 Others
1.3 Global Biological Drugs Market Size by Type
1.3.1 Global Biological Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Biological Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Biological Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Biological Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Biological Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Biological Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Biological Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Biological Drugs Sales Breakdown by Type (2018-2023)
2 Global Biological Drugs Market Competition by Company
2.1 Global Top Players by Biological Drugs Sales (2018-2023)
2.2 Global Top Players by Biological Drugs Revenue (2018-2023)
2.3 Global Top Players by Biological Drugs Price (2018-2023)
2.4 Global Top Manufacturers Biological Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Biological Drugs Market Competitive Situation and Trends
2.5.1 Biological Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Biological Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biological Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Biological Drugs Market
2.8 Key Manufacturers Biological Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Biological Drugs Status and Outlook by Region
3.1 Global Biological Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Biological Drugs Historic Market Size by Region
3.2.1 Global Biological Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Biological Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Biological Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Biological Drugs Forecasted Market Size by Region
3.3.1 Global Biological Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Biological Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Biological Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Biological Drugs by Application
4.1 Biological Drugs Market Segment by Application
4.1.1 Hospitals
4.1.2 Ambulatory Surgical Centers
4.1.3 Others
4.2 Global Biological Drugs Market Size by Application
4.2.1 Global Biological Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Biological Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Biological Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Biological Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Biological Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Biological Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Biological Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Biological Drugs Sales Breakdown by Application (2018-2023)
5 North America Biological Drugs by Country
5.1 North America Biological Drugs Historic Market Size by Country
5.1.1 North America Biological Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Biological Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Biological Drugs Sales in Value by Country (2018-2023)
5.2 North America Biological Drugs Forecasted Market Size by Country
5.2.1 North America Biological Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Biological Drugs Sales in Value by Country (2024-2029)
6 Europe Biological Drugs by Country
6.1 Europe Biological Drugs Historic Market Size by Country
6.1.1 Europe Biological Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Biological Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Biological Drugs Sales in Value by Country (2018-2023)
6.2 Europe Biological Drugs Forecasted Market Size by Country
6.2.1 Europe Biological Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Biological Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Biological Drugs by Region
7.1 Asia-Pacific Biological Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Biological Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Biological Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Biological Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Biological Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Biological Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Biological Drugs Sales in Value by Region (2024-2029)
8 Latin America Biological Drugs by Country
8.1 Latin America Biological Drugs Historic Market Size by Country
8.1.1 Latin America Biological Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Biological Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Biological Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Biological Drugs Forecasted Market Size by Country
8.2.1 Latin America Biological Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Biological Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Biological Drugs by Country
9.1 Middle East and Africa Biological Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Biological Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Biological Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Biological Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Biological Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Biological Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Biological Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bristol-Myers Squibb
10.1.1 Bristol-Myers Squibb Company Information
10.1.2 Bristol-Myers Squibb Introduction and Business Overview
10.1.3 Bristol-Myers Squibb Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bristol-Myers Squibb Biological Drugs Products Offered
10.1.5 Bristol-Myers Squibb Recent Development
10.2 Eli Lilly
10.2.1 Eli Lilly Company Information
10.2.2 Eli Lilly Introduction and Business Overview
10.2.3 Eli Lilly Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Eli Lilly Biological Drugs Products Offered
10.2.5 Eli Lilly Recent Development
10.3 Takeda
10.3.1 Takeda Company Information
10.3.2 Takeda Introduction and Business Overview
10.3.3 Takeda Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Takeda Biological Drugs Products Offered
10.3.5 Takeda Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer Biological Drugs Products Offered
10.4.5 Pfizer Recent Development
10.5 Amgen
10.5.1 Amgen Company Information
10.5.2 Amgen Introduction and Business Overview
10.5.3 Amgen Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Amgen Biological Drugs Products Offered
10.5.5 Amgen Recent Development
10.6 F. Hoffmann-La Roche
10.6.1 F. Hoffmann-La Roche Company Information
10.6.2 F. Hoffmann-La Roche Introduction and Business Overview
10.6.3 F. Hoffmann-La Roche Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 F. Hoffmann-La Roche Biological Drugs Products Offered
10.6.5 F. Hoffmann-La Roche Recent Development
10.7 Johnson & Johnson
10.7.1 Johnson & Johnson Company Information
10.7.2 Johnson & Johnson Introduction and Business Overview
10.7.3 Johnson & Johnson Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Johnson & Johnson Biological Drugs Products Offered
10.7.5 Johnson & Johnson Recent Development
10.8 Merck
10.8.1 Merck Company Information
10.8.2 Merck Introduction and Business Overview
10.8.3 Merck Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Merck Biological Drugs Products Offered
10.8.5 Merck Recent Development
10.9 Abbott Laboratories
10.9.1 Abbott Laboratories Company Information
10.9.2 Abbott Laboratories Introduction and Business Overview
10.9.3 Abbott Laboratories Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Abbott Laboratories Biological Drugs Products Offered
10.9.5 Abbott Laboratories Recent Development
10.10 Baxter
10.10.1 Baxter Company Information
10.10.2 Baxter Introduction and Business Overview
10.10.3 Baxter Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Baxter Biological Drugs Products Offered
10.10.5 Baxter Recent Development
10.11 Novartis
10.11.1 Novartis Company Information
10.11.2 Novartis Introduction and Business Overview
10.11.3 Novartis Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Novartis Biological Drugs Products Offered
10.11.5 Novartis Recent Development
10.12 Biogen
10.12.1 Biogen Company Information
10.12.2 Biogen Introduction and Business Overview
10.12.3 Biogen Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Biogen Biological Drugs Products Offered
10.12.5 Biogen Recent Development
10.13 GlaxoSmithKline
10.13.1 GlaxoSmithKline Company Information
10.13.2 GlaxoSmithKline Introduction and Business Overview
10.13.3 GlaxoSmithKline Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 GlaxoSmithKline Biological Drugs Products Offered
10.13.5 GlaxoSmithKline Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Biological Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Biological Drugs Industrial Chain Analysis
11.4 Biological Drugs Market Dynamics
11.4.1 Biological Drugs Industry Trends
11.4.2 Biological Drugs Market Drivers
11.4.3 Biological Drugs Market Challenges
11.4.4 Biological Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Biological Drugs Distributors
12.3 Biological Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
